BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16226231)

  • 1. Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain.
    Kim JB; Yu YM; Kim SW; Lee JK
    Brain Res; 2005 Oct; 1060(1-2):188-92. PubMed ID: 16226231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
    Yu YM; Kim JB; Lee KW; Kim SY; Han PL; Lee JK
    Stroke; 2005 Oct; 36(10):2238-43. PubMed ID: 16141417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
    Kim SW; Jeong JY; Kim HJ; Seo JS; Han PL; Yoon SH; Lee JK
    Neurotox Res; 2010 Jan; 17(1):39-49. PubMed ID: 19636661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of OBA-09, a salicylic acid/pyruvate ester, in the postischemic brain.
    Lee HK; Kim SW; Jin Y; Kim ID; Park JY; Yoon SH; Lee JK
    Brain Res; 2013 Aug; 1528():68-79. PubMed ID: 23850644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain.
    Shin JH; Lee HK; Lee HB; Jin Y; Lee JK
    Neurosci Lett; 2014 Jan; 558():159-63. PubMed ID: 24246904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethyl pyruvate protects PC12 cells from oxygen-glucose deprivation: A potential role in ischemic cerebrovascular disease.
    Li W; Lou J; Wei L; Bai H; Zhang Y; He Y
    Biomed Pharmacother; 2017 Aug; 92():168-174. PubMed ID: 28538193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain.
    Lee HK; Kim ID; Kim SW; Lee H; Park JY; Yoon SH; Lee JK
    Sci Rep; 2017 Feb; 7():42891. PubMed ID: 28220827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethyl pyruvate ameliorates 3-nitropropionic acid-induced striatal toxicity through anti-neuronal cell death and anti-inflammatory mechanisms.
    Jang M; Lee MJ; Cho IH
    Brain Behav Immun; 2014 May; 38():151-65. PubMed ID: 24576481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain.
    Lee HK; Park JY; Lee H; Kim ID; Kim SW; Yoon SH; Lee JK
    Neurotherapeutics; 2019 Apr; 16(2):523-537. PubMed ID: 30680637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms.
    Shen H; Hu X; Liu C; Wang S; Zhang W; Gao H; Stetler RA; Gao Y; Chen J
    Neurobiol Dis; 2010 Mar; 37(3):711-22. PubMed ID: 20026271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of ethyl pyruvate against Zn(2+) toxicity via NAD replenishment and direct Zn(2+) chelation.
    Kim SW; Lee HK; Kim HJ; Yoon SH; Lee JK
    Neuropharmacology; 2016 Jun; 105():411-419. PubMed ID: 26850126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect.
    Lim CM; Kim SW; Park JY; Kim C; Yoon SH; Lee JK
    J Neurosci Res; 2009 Mar; 87(4):1037-45. PubMed ID: 18855941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury.
    Shi H; Wang HL; Pu HJ; Shi YJ; Zhang J; Zhang WT; Wang GH; Hu XM; Leak RK; Chen J; Gao YQ
    CNS Neurosci Ther; 2015 Apr; 21(4):374-84. PubMed ID: 25533312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window.
    Lanzillotta A; Pignataro G; Branca C; Cuomo O; Sarnico I; Benarese M; Annunziato L; Spano P; Pizzi M
    Neurobiol Dis; 2013 Jan; 49():177-89. PubMed ID: 22971966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: involvement of anti-oxidation and anti-inflammation through nuclear transcription factor κappaB signaling pathway.
    Liu R; Zhang L; Lan X; Li L; Zhang TT; Sun JH; Du GH
    Neuroscience; 2011 Mar; 176():408-19. PubMed ID: 21168474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of FK506-mediated neuroprotection: downregulation of cytokine expression in glial cells.
    Zawadzka M; Kaminska B
    Glia; 2005 Jan; 49(1):36-51. PubMed ID: 15390105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats.
    Yasuda N; Ishii T; Oyama D; Fukuta T; Agato Y; Sato A; Shimizu K; Asai T; Asakawa T; Kan T; Yamada S; Ohizumi Y; Oku N
    Brain Res; 2014 Apr; 1559():46-54. PubMed ID: 24534366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain.
    Lin CH; Wang CH; Hsu SL; Liao LY; Lin TA; Hsueh CM
    PLoS One; 2016; 11(1):e0146692. PubMed ID: 26745377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.
    Guan T; Liu Q; Qian Y; Yang H; Kong J; Kou J; Yu B
    Eur J Pharmacol; 2013 Aug; 714(1-3):303-11. PubMed ID: 23911884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.